Neryda Duncan

Neryda has been part of the MARS Bioimaging journey since 2017, completing her PhD with the company before moving into programme management and operations. With a background in engineering, medical physics, and physics research, she has a strong foundation for coordinating complex, cross-functional teams. In her current role, Neryda leads the delivery of major projects that is bringing MARS’s next-gen imaging technology closer to real-world healthcare.

Hear from Neryda on the “The Future of Imaging”.
MARS Bioimaging is a company transforming the world of medical imaging with colour 3D x-ray technology. Their spectral CT scanners, developed from CERN-based tech, go beyond traditional black-and-white images to show detailed, full-colour views inside the body, leading to better diagnosis and enhancing patient outcomes.
This session will focus on the future of imaging: how this ultra‑high‑resolution colour imaging technology is redefining diagnostic capabilities as the company moves towards global rollout of its point‑of‑care scanners.